S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)

The 10 Top-Rated Stocks by Wall Street Analysts in June 2021

Wednesday, June 30, 2021 | Chris Markoch
The 10 Top-Rated Stocks by Wall Street Analysts in May 2021

Analyst ratings are an imperfect science. However, they do reflect the sentiment of individuals who have significant knowledge of a company’s operations. Ratings are done on a scale from 1.00 to 4.00. A score of 4.00 is equivalent to a “strong buy” rating. By contrast a score of 1.00 is equivalent to a “sell” rating. For a company to be included on MarketBeat’s list they must have received at least five ratings within the last 12 months. Here are the top 10 top-rated stocks by Wall Street analysts in June 2021:

  1. AltaGas (OTCMKTS:ATGFF) – Traditional energy stocks have been making a comeback in 2021. So it shouldn’t be that much of a surprise that AltaGas tops this list. ATGFF stock is up over 44% in 2021 and has a consensus score of 3.10 among 10 analysts. The company’s stock is projected to have an upside of over 26% in the next 12 months.
  2. Teleflex (NYSE:TFX) – Another market sector that is expected to perform well in 2021 is the medical equipment sector. Elective surgeries were delayed in 2020 due to the Covid-19 pandemic. However as hospitals and medical centers look to recoup that revenue in 2021, there is a big opportunity for Teleflex which manufactures specialty medical devices. The stock is flat for the year. However, 10 analysts give TFX stock a score of 3.10 with an upside of over 14%.
  3. Brigham Minerals (NYSE:MNRL) – Brigham Minerals is another highly rated stock in the energy sector. Specifically, Brigham Minerals focuses on acquiring oil and gas rights from landowners throughout the United States. MNRL stock is up 84% in 2021 and has a 3.10 rating among 10 analysts. A note of caution is in order as the consensus price target has the stock dropping by 21% over the next 12 months. However, the company reports earnings in August and that may change the outlook.
  4. Vodafone Group (NASDAQ:VOD) –Vodafone is a multinational telecommunications company headquartered in the United Kingdom. VOD stock is flat for the year as the economic reopening in Europe has not been as smooth as in the United States. Still at one point, the stock was up 20% for the year. And analysts give the stock a 3.10 rating suggesting that the stock is likely to grow strongly in the second half of 2021.
  5. CymaBay Therapeutics (NASDAQ:CBAY) – As the race for a Covid-19 vaccine comes to a conclusion, investors are looking at other biotech companies. And at this time, they like what they are seeing from CymaBay Therapeutics. The company’s stock is up approximately 28% in the 12 months ending on June 28. However, CBAY stock is down about 21% in 2021. Still, the company has a consensus rating among 10 analysts of 3.09. And the company’s stock price is projected to grow by 138% for the remainder of 2021.
  6. Health Catalyst (NASDAQ:HCAT) – Health Catalyst positions investors in the healthcare and data analytics sectors. HCAT stock has a 3.09 rating among 11 analysts, but the consensus price target shows a 14% downside risk in the next 12 months. However, revenue has been trending in a positive direction and the company is getting closer to becoming profitable. Analysts will be looking for this trend to continue when the company reports earnings in August.
  7. Tourmaline Oil (OTCMKTS:TRMLF) – Returning to oil stocks, we have Tourmaline Oil which has a consensus rating of 3.09 among 11 analysts. With the price of crude oil expected to continue to rise in 2021, it’s no surprise that TRMLF stock is projected to have upside price growth of over 47%. That would continue its strong upward movement in 2021 in which the stock is up over 96%.
  8. Gaming and Leisure Properties (NASDAQ:GLPI) – The gaming industry is another area of strong growth for the market in 2021. Gaming and Leisure Properties is a real estate investment trust (REIT) that has an innovative model in which they enter into triple-net lease agreements with gaming operators. The stock is up nearly 13% in 2021 and analysts give the stock a possible upside of over 8% in the next 12 months. The stock carries a 3.08 rating among 12 analysts.
  9. Rackspace Technology (NASDAQ:RXT) – Rackspace Technology is a global cloud services company. Like many stocks in the tech sector, RXT stock has been volatile this year. However, analysts give the stock a 3.08 rating with a possible upside of over 42% in the next 12 months, which would be more than double the growth of the stock in the past 12 months.
  10. S&P Global (NYSE:SPGI) – S&P Global provides ratings, benchmarks, analytics and data to global capital and commodity markets. SPGI stock is up over 23% in 2021 and over 28% in the last 12 months. The stock receives a 3.08 rating among the 12 analysts that provide coverage. While the consensus price target suggests little upside, recent analyst reports have come with boosted price targets.

Should you invest $1,000 in right now?

Before you consider , you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and wasn't on the list.

While currently has a "" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
CymaBay Therapeutics (CBAY)2.0$3.80-2.3%N/A-3.84Buy$10.13
Vodafone Group (VOD)2.5$15.85-0.9%6.56%16.86Buy$16.67
Brigham Minerals (MNRL)1.9$19.36-0.4%7.23%-29.33Buy$17.62
Teleflex (TFX)2.6$388.09-0.3%0.35%52.37Buy$455.80
Health Catalyst (HCAT)2.0$53.70-0.7%N/A-17.10Buy$61.10
Tourmaline Oil (TRMLF)1.9$34.59+1.7%N/AN/ABuy$50.69
Gaming and Leisure Properties (GLPI)2.1$47.30-1.0%5.67%19.31Buy$50.54
Rackspace Technology (RXT)2.6$13.99-1.4%N/A-10.36Buy$21.56
S&P Global (SPGI)2.7$453.08+0.3%0.68%44.51Buy$463.90
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.